FA
CRSP icon

Faithward Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Faithward Advisors’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,228
Closed -$341K – 246
2020
Q4 		$341K Buy
+2,228
New +$341K 0.15% 57